▲ Peaking
Business
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals reshapes biotech M&A with $10B Crinetics acquisition
3 trends tracked about this subject — the full history, oldest to newest below.
Vertex Pharmaceuticals reshapes biotech M&A with $10B Crinetics acquisition
Ipsen’s $1.75B bid for Kartos Therapeutics reshapes blood cancer drug development—with a twist on the deal’s structure
AbbVie’s $10.9B bid for Apogee Therapeutics reshapes biotech M&A landscape overnight